VAC Regimen for AML Patients Who Failed to Response to VA Regimen

NCT06220162 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: chidamide in combination with venetoclax and azacitidine (VAC)

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]